HIV Diagnosis Market Report

The diagnostic of HIV identifies the presence of the human immunodeficiency infection (HIV), the virus that causes the Acquired Immunodeficiency Syndrome (AIDS). This is done via completing certain tests in serum, saliva, or urine samples. These tests may distinguish antibodies, antigens, or RNA. The growing awareness about HIV, secrecy of the test, and appropriate counselling increases the interest for this diagnosis procedure.  The HIV diagnosis can be done by blood test, saliva test, viral load test, though the most efficient test results are obtained by Enzyme Linked Immunosorbent Assay (ELISA) test initially and later by Western Bloat Method. 

HIV Diagnosis Market Outlook

The HIV Diagnosis Market is mainly driven by the increasing prevalence of HIV/AIDS globally coupled with the various governmental initiatives by countries to create the awareness of HIV. As per Avert Organisation, an estimated 36.9 million people were affected by HIV in 2017 (including 1.8 million children), with a global HIV prevalence of 0.8% among adults. In same year, 940,000 deaths were recorded due to the AIDS-related illnesses.  The vast majority of people living with HIV are located in low- and middle- income countries. Further, increasing number of blood transfusions and blood donations which, changing lifestyle among the populace and benefits offered by point-of-care instruments & kits are the factors that are anticipated to boost the growth of the market.  On the down side, high costs of Nucleic Acid Testing (NAT) and lack of awareness for NAT in the diagnostic of HIV mainly in the developing countries are the factors that are likely to impede the growth of the market. 

HIV Diagnosis Market Segmental Overview

The report analyses the HIV Diagnosis Market based on products, test types, end user and geography.

HIV Diagnosis Market by Product 

On the basis of product and service, the market is bifurcated into Blood Culture Media, Instruments, Assays & Reagents and Software. The assay and reagents  segment is anticipated to hold for the major share of the market. This can be attributed to the need of the frequent and repetitive purchase of consumables by laboratories and hospitals coupled with the growing initiatives from governments to fight HIV/AIDS and increasing initiatives from governments for the diagnosis of the HIV. 

HIV Diagnosis Market by Test Types 

Based upon test type, the global HIV diagnosis market is bifurcated into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further classified into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. Further, HIV-1 Screening Tests sub segment comprises of Elisa, Rapid Tests and Home Access Dried Blood Spots. Also, HIV-1 Antibody Confirmatory Tests includes Western Blot Tests, Indirect Immunofluorescence Assays (IFA), Line Immunoassays and Radio-Immunoprecipitation Assays.  The antibody tests segment is expected to hold the significant revenue share of the market owing to the increasing technological advancements in HIV diagnosis, coupled with the growing awareness among people concerning to regular blood tests.

HIV Diagnosis Market by End User 

The HIV diagnosis market by end user, is bifurcated into diagnostic laboratories, hospitals, blood banks, home care settings, and others. The diagnostic laboratories segment is dominated the market due to the high investment and technological advancements of diagnostics laboratories along with the increasing awareness of HIV Diagnosis 

HIV Diagnosis Market by Geography 

Geographically, the global HIV Diagnosis Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

North America dominates the HIV diagnostics market due to supportive government initiatives and funding in order to increase HIV diagnosis procedures and create awareness among the population and increase in demand of HIV diagnosis products in North America. For the North-America region, US government is allocating significant budget for research and development in the area of HIV/AIDS diagnosis and favourable reimbursements policies in the region by the government is encouraging the people to take the HIV diagnostics test which is a driving the HIV diagnostics market in this region.

Asia Pacific is an emerging market for HIV diagnostics, due to increasing patient population suffering from HIV/AIDS and to generate the awareness among the population is pulling the HIV diagnostics market for this region.

Market Key Players 

The key players operating the HIV Diagnostics Market globally are Abbott Healthcare, BD Biosciences, Roche Diagnostics, Zyomyx Incorporation, Merck & Company Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, Hologic Incorporation, Chembio Diagnostic Systems, Alere Incorporation, Sysmex Incorporation Gilead Sciences, Qiagen,  VIIV healthcare, Beckman Coulter  and many others.